About ▼ Careers Internship MedBlog Contact us

Elekta's MOSAIQ is Once Again "Category Leader" in Oncology Information Systems, Receiving Top Score in Best in KLAS: Software & Services Report

http://mb.cision.com/Main/35/2177616/621729.pdf

PDF

Latest Press Release on Cancer News

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting

TEL AVIV, Israel , April 17, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in onco...

Biotech Innovations Paving the Way in Breast Cancer Fight

FN Media Group Presents USA News Group News Commentary VANCOUVER, BC , April 11, 2024 /PRNewswire/ -- USA News Group – The American Cancer Society is projecting 20...

Recommendations for Head and Neck Cancer Awareness Month from the American Board of Oral and Maxillofacial Surgery

To promote public awareness of head and neck cancer, board-certified oral and maxillofacial surgeons share facts and tips CHICAGO , April 11, 2024 /PRNewswire/ -- The Executiv...

Stamford Pharmaceuticals Inc Announces the First Patient to Be Treated with SP-002 in Combination with Erivedge® in a Phase 2 Study in Locally Advanced BCC Subjects

AUSTIN, Texas , April 11, 2024 /PRNewswire/ -- Stamford Pharmaceuticals Inc, a clinical-stage biotechnology company developing science-driven immune therapies, today announced ini...

Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol

CLEVELAND , April 11, 2024 /PRNewswire/ -- More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud to announce its pioneering effort to combat...

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close